心不全患者における低酸素応答性と腸内発酵能:予備的結果
Aleksandra Mikołajczak1,2, Rafał Seredyński1, Marzena Gonerska1
1Department of Physiology and Pathophysiology, Wroclaw Medical University, Wroclaw, Poland.
Frontiers in physiology
|January 26, 2026
まとめ
ラクツロースによる腸内発酵の促進は、心不全(HF)患者の末梢化学受容器感度を改善する可能性がある。これは、HFにおける腸内細菌叢と心血管調節との関連を示唆している。
科学分野:
- 心血管生理学
- 消化器病学
- マイクロバイオーム研究
背景:
- 腸内細菌叢は心血管調節に大きく影響する。
- ラクツロース誘発性発酵は、健常者において低酸素換気応答(HVR)および末梢化学受容器(PCh)応答性を高める。
- 心不全(HF)はPChの過活動亢進と関連しており、介入の標的となっている。
研究 の 目的:
- 腸内発酵を刺激することが、心不全患者における化学受容器駆動性の心血管および換気応答を急性的に変化させるかどうかを調査すること。
- 心不全における腸内発酵能とPCh感度の関係を探求すること。
主な方法:
- 12名の男性心不全患者が、腸内発酵刺激食摂取の前後に2回の一過性低酸素試験を受けた。
- 呼気中水素濃度を測定し、患者を高早期発酵(HEF)群と低早期発酵(LEF)群に分類した。
- 低酸素に対する換気(HVR)および心血管(心拍数、血圧、全身血管抵抗)応答を評価した。
主要な成果:
- HEF患者はLEF患者と比較して有意に高いHVRを示した(p=0.024)。
- HEF患者は、ラクツロース投与の前後に、低酸素に対する全身血管抵抗(SVR)の反応がより顕著であった(それぞれp=0.039およびp=0.026)。
- HEF患者では、HVRと純水素排泄量との間に強い相関が観察された(r=0.85、p=0.033)。
結論:
- 予備的所見は、心不全患者における上部消化管の細菌発酵能とベースラインの末梢化学受容器反射感度との関連を示唆している。
- 本研究は、心不全における心血管調節管理において、腸内発酵調節の潜在的な役割を強調している。
- これらの探索的所見とその臨床的意義を確認するためには、より大規模な対照研究が必要である。
さらに関連する動画
04:20Integration of Brain Tissue Saturation Monitoring in Cardiopulmonary Exercise Testing in Patients with Heart Failure
Published on: October 1, 2019
6.2K
06:58Analysis of Interactions between Endobiotics and Human Gut Microbiota Using In Vitro Bath Fermentation Systems
Published on: August 23, 2019
7.5K
関連する概念動画
Fermentation
129.1K
Most eukaryotic organisms require oxygen to survive and function adequately. Such organisms produce large amounts of energy during aerobic respiration by metabolizing glucose and oxygen into carbon dioxide and water. However, most eukaryotes can generate some energy in the absence of oxygen by anaerobic metabolism.
Fermentation is a type of metabolic process that occurs in the absence of oxygen, where organic molecules such as glucose are broken down to produce energy. During this process, the...
Fermentation is a type of metabolic process that occurs in the absence of oxygen, where organic molecules such as glucose are broken down to produce energy. During this process, the...
129.1K
Pathophysiology of Heart Failure
3.4K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.4K
Heart Failure I: Introduction
829
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
829
Heart Failure II: Pathophysiology
855
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
855
Heart Failure Drugs: Diuretics
935
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
935
Heart Failure V: Medical Management
267
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
267
